Analysen von Charles Pitman-King
| 06.02.26 | Bayer Overweight | Barclays Capital | |
| 05.02.26 | Bayer Overweight | Barclays Capital | |
| 04.02.26 | Sartorius vz. Overweight | Barclays Capital | |
| 03.02.26 | Sartorius vz. Overweight | Barclays Capital | |
| 03.02.26 | Merck Equal Weight | Barclays Capital | |
| 07.01.26 | Merck Equal Weight | Barclays Capital | |
| 07.01.26 | Sartorius Stedim Biotech Overweight | Barclays Capital | |
| 07.01.26 | Sartorius vz. Overweight | Barclays Capital | |
|
Werbung
|
|||
| 07.01.26 | Bayer Overweight | Barclays Capital | |
| 02.12.25 | Bayer Equal Weight | Barclays Capital | |
| 24.11.25 | Bayer Equal Weight | Barclays Capital | |
| 01.10.25 | Sartorius Stedim Biotech Overweight | Barclays Capital | |
| 01.10.25 | Sartorius vz. Overweight | Barclays Capital | |
| 23.07.25 | Sartorius vz. Overweight | Barclays Capital | |
| 18.06.25 | Sartorius vz. Overweight | Barclays Capital | |
| 12.05.25 | Merck Overweight | Barclays Capital | |
| 26.02.25 | Sartorius vz. Overweight | Barclays Capital | |